These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9030988)

  • 21. Paraneoplastic syndromes affecting the central nervous system.
    Posner JB; Dalmau JO
    Annu Rev Med; 1997; 48():157-66. PubMed ID: 9046952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anticerebellar antibodies--anti-Hu and anti-Yo--in the diagnosis of paraneoplastic neurologic syndromes].
    Grisold W; Drlicek M; Liszka U
    Nervenarzt; 1991 Oct; 62(10):609-14. PubMed ID: 1749452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
    Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
    No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies in neurological paraneoplastic diseases.
    Lövblad KO; Boucraut J; Lehmann HP; Stahel R; Regli F; Steck AJ
    Schweiz Arch Neurol Psychiatr (1985); 1994; 145(3):3-7. PubMed ID: 7533934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. POP66, a paraneoplastic encephalomyelitis-related antigen, is a marker of adult oligodendrocytes.
    Honnorat J; Aguera M; Zalc B; Goujet C; Quach T; Antoine JC; Belin MF
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):311-22. PubMed ID: 9600223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer.
    Anderson NE; Rosenblum MK; Graus F; Wiley RG; Posner JB
    Neurology; 1988 Sep; 38(9):1391-8. PubMed ID: 2842702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internalization of anti-Hu IgG is not Fc gamma receptor mediated.
    Hormigo A; Ball C; Lieberman F
    Neurology; 1996 Aug; 47(2):607-9. PubMed ID: 8757057
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies.
    Graus F; Vega F; Delattre JY; Bonaventura I; Reñé R; Arbaiza D; Tolosa E
    Neurology; 1992 Mar; 42(3 Pt 1):536-40. PubMed ID: 1312683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia.
    Yang YY; Yin GL; Darnell RB
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13254-9. PubMed ID: 9789075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hippocampal protein associated with paraneoplastic neurologic syndrome and small cell lung carcinoma.
    Sakai K; Gofuku M; Kitagawa Y; Ogasawara T; Hirose G; Yamazaki M; Koh CS; Yanagisawa N; Steinman L
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1200-8. PubMed ID: 7511893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration.
    Dropcho EJ; Chen YT; Posner JB; Old LJ
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4552-6. PubMed ID: 3474619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hu antigens and anti-Hu antibodies in a patient with myxoid chondrosarcoma.
    Verschuuren J; Twijnstra A; De Baets M; Thunnissen F; Dalmau J; van Breda Vriesman P
    Neurology; 1994 Aug; 44(8):1551-2. PubMed ID: 8058170
    [No Abstract]   [Full Text] [Related]  

  • 33. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
    Manley GT; Smitt PS; Dalmau J; Posner JB
    Ann Neurol; 1995 Jul; 38(1):102-10. PubMed ID: 7541976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New concepts in paraneoplastic neurological syndromes.
    Honnorat J; Viaccoz A
    Rev Neurol (Paris); 2011 Oct; 167(10):729-36. PubMed ID: 21890156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoimmune mechanisms in the pathogenesis of neurologic paraneoplastic diseases].
    Pelikán F; Timová S
    Bratisl Lek Listy; 1997 Jun; 98(6):335-8. PubMed ID: 9333425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurological paraneoplastic syndromes.
    Nath U; Grant R
    J Clin Pathol; 1997 Dec; 50(12):975-80. PubMed ID: 9516876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis.
    Voltz R; Dalmau J; Posner JB; Rosenfeld MR
    Neurology; 1998 Oct; 51(4):1146-50. PubMed ID: 9781545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies.
    Buckanovich RJ; Yang YY; Darnell RB
    J Neurosci; 1996 Feb; 16(3):1114-22. PubMed ID: 8558240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of plasmapheresis on serum and CSF autoantibody levels in CNS paraneoplastic syndromes.
    Graus F; Abos J; Roquer J; Mazzara R; Pereira A
    Neurology; 1990 Oct; 40(10):1621-3. PubMed ID: 2215957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraneoplastic neurologic syndromes.
    Hinton RC
    Hematol Oncol Clin North Am; 1996 Aug; 10(4):909-25. PubMed ID: 8811308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.